Cerebras Systems (CBRS) exploded onto the Nasdaq on Thursday with a 68% first-day pop — the biggest tech IPO since Uber hit the public markets in 2019...
Remote work isn't new, but how we do it keeps changing. In 2026, the average tech company has employees in 4+ time zones, uses 7-10 different tools da...
Meta Description: A practical guide to making remote work actually work for engineering and product teams in 2026. From async communication to te...
Nvidia CEO Jensen Huang is on Air Force One right now — heading to Beijing alongside President Donald Trump for a high-stakes summit with Chinese Pres...
Google caught something historic last week: the first confirmed AI-written zero-day exploit being prepped for a mass cyberattack in the wild. A crime ...
Databricks just repriced 40% higher to $188 billion in seven months — a ~$3B round led by Coatue, still stubbornly private, and quietly running the AI economy's plumbing.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Developer documentation is the silent killer of product adoption. A 2025 study by the Developer Marketing Alliance found that 67% of developers will a...
Vera Therapeutics just won FDA accelerated approval for TRUTAKNA, the first dual BAFF/APRIL inhibitor for IgA nephropathy — priced at $425,000 a year. Here's why the two-target bet matters.
Feature Image: https://images.unsplash.com/photo-1648792940059-3b782a7b8b20?crop=entropy&cs=tinysrgb&fit=max&fm=jpg&ixid=M3w3ODQzODd8MHwxfHNlYXJj...
BREAKING NEWS — In a move that signals the pharmaceutical industry's full-scale embrace of artificial intelligence, Swiss healthcare giant Roche has ...
